254 related articles for article (PubMed ID: 23501583)
1. [Immune response and colorectal cancer].
Tougeron D; Fauquembergue E; Latouche JB
Bull Cancer; 2013 Mar; 100(3):283-94. PubMed ID: 23501583
[TBL] [Abstract][Full Text] [Related]
2. Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers.
Schwitalle Y; Kloor M; Eiermann S; Linnebacher M; Kienle P; Knaebel HP; Tariverdian M; Benner A; von Knebel Doeberitz M
Gastroenterology; 2008 Apr; 134(4):988-97. PubMed ID: 18395080
[TBL] [Abstract][Full Text] [Related]
3. Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies.
Atreya I; Neurath MF
Expert Rev Anticancer Ther; 2008 Apr; 8(4):561-72. PubMed ID: 18402523
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell and macrophage infiltration in microsatellite-unstable and microsatellite-stable colorectal cancer.
Bauer K; Michel S; Reuschenbach M; Nelius N; von Knebel Doeberitz M; Kloor M
Fam Cancer; 2011 Sep; 10(3):557-65. PubMed ID: 21598004
[TBL] [Abstract][Full Text] [Related]
5. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
6. The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer.
Roxburgh CS; McMillan DC
Cancer Treat Rev; 2012 Aug; 38(5):451-66. PubMed ID: 21945823
[TBL] [Abstract][Full Text] [Related]
7. Colorectal Cancer Immune Infiltrates: Significance in Patient Prognosis and Immunotherapeutic Efficacy.
Guo L; Wang C; Qiu X; Pu X; Chang P
Front Immunol; 2020; 11():1052. PubMed ID: 32547556
[TBL] [Abstract][Full Text] [Related]
8. Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic.
Phillips SM; Banerjea A; Feakins R; Li SR; Bustin SA; Dorudi S
Br J Surg; 2004 Apr; 91(4):469-75. PubMed ID: 15048750
[TBL] [Abstract][Full Text] [Related]
9. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
10. Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers.
Speetjens FM; Kuppen PJ; Morreau H; van der Burg SH
Gastroenterology; 2008 Aug; 135(2):711-2; author reply 712-3. PubMed ID: 18619460
[No Abstract] [Full Text] [Related]
11. [Research progression in tumor-infiltration lymphocytic cells in colorectal cancer].
Zhai ZW; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Aug; 16(8):797-800. PubMed ID: 23980054
[TBL] [Abstract][Full Text] [Related]
12. [Immunotherapy for colorectal cancer].
Tougeron D; Fauquembergue É; Latouche JB
Bull Cancer; 2013 Sep; 100(9):871-85. PubMed ID: 23917703
[TBL] [Abstract][Full Text] [Related]
13. High-resolution genomic analysis: the tumor-immune interface comes into focus.
Havel JJ; Chan TA
Genome Biol; 2015 Mar; 16(1):65. PubMed ID: 25853850
[TBL] [Abstract][Full Text] [Related]
14. High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability.
Michel S; Benner A; Tariverdian M; Wentzensen N; Hoefler P; Pommerencke T; Grabe N; von Knebel Doeberitz M; Kloor M
Br J Cancer; 2008 Dec; 99(11):1867-73. PubMed ID: 18985040
[TBL] [Abstract][Full Text] [Related]
15. Investigation of miRNA dysregulation and association with immune cell profile during malignant transformation of colorectal cells.
Ng L; Li X; Wan TM; Iyer D; Sin RW; Lo OS; Foo DC; Law WL
Eur J Surg Oncol; 2022 Jan; 48(1):245-252. PubMed ID: 34620510
[TBL] [Abstract][Full Text] [Related]
16. The high expression of Fractalkine results in a better prognosis for colorectal cancer patients.
Ohta M; Tanaka F; Yamaguchi H; Sadanaga N; Inoue H; Mori M
Int J Oncol; 2005 Jan; 26(1):41-7. PubMed ID: 15586223
[TBL] [Abstract][Full Text] [Related]
17. Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer.
Michael-Robinson JM; Pandeya N; Walsh MD; Biemer-Huttmann AE; Eri RD; Buttenshaw RL; Lincoln D; Clouston AD; Jass JR; Radford-Smith GL
J Pathol; 2006 Feb; 208(3):381-7. PubMed ID: 16315333
[TBL] [Abstract][Full Text] [Related]
18. High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer.
Hojo S; Koizumi K; Tsuneyama K; Arita Y; Cui Z; Shinohara K; Minami T; Hashimoto I; Nakayama T; Sakurai H; Takano Y; Yoshie O; Tsukada K; Saiki I
Cancer Res; 2007 May; 67(10):4725-31. PubMed ID: 17510400
[TBL] [Abstract][Full Text] [Related]
19. Escape mechanisms in tumor immunity: an update.
Müller L; Kiessling R; Rees RC; Pawelec G
J Environ Pathol Toxicol Oncol; 2002; 21(4):277-330. PubMed ID: 12510961
[TBL] [Abstract][Full Text] [Related]
20. The influence of host response on colorectal cancer prognosis.
Shunyakov L; Ryan CK; Sahasrabudhe DM; Khorana AA
Clin Colorectal Cancer; 2004 May; 4(1):38-45. PubMed ID: 15207019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]